BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220623T090000
DTEND;TZID=America/New_York:20220623T120000
DTSTAMP:20260530T232716
CREATED:20220525T203315Z
LAST-MODIFIED:20220525T204305Z
UID:6208-1655974800-1655985600@carb-x.org
SUMMARY:Global Vaccine and Immunization Research Forum
DESCRIPTION:Topic:\nVaccines as Tools to Prevent Antimicrobial Resistance: Advances\, Challenges and Future Development \nPurpose:\nAntimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections\, reducing antibiotic use and reducing pathogen transmission and chances of developing resistance genes. Increasing evidence from observational and modelling studies show the impact of vaccines on AMR. \nHowever\, this evidence is yet to translate to policy and decision making about which vaccines to develop and introduce\, so they effectively prevent AMR. This webinar will explore the mechanisms\, evidence and value of vaccines in preventing AMR. A panel of experts will discuss the challenges to ensure that vaccines to prevent AMR are developed and widely used. \nRegistration:\nhttps://who.zoom.us/webinar/register/WN_Iudu_2LtRIqv6hA6IkCkBQ \nAudience\nScientists\, product developers\, regulators\, policy makers\, implementers and funders interested in the role of vaccines in preventing AMR. \nTopics \n\nThe threat of AMR and ways through which vaccines can prevent it;\nAssessment of the value of vaccines in preventing AMR;\nResearch priorities on vaccines and AMR;\nDevelopment pipeline for vaccines against AMR priority pathogens;\nThe role of vaccines in National Action Plans on AMR;\nStories from the field: how vaccines were used in Zimbabwe to prevent AMR;\nChallenges and opportunities to ensure that vaccines against AMR are developed and used.\n\nAbout GVIRF\nThe Global Vaccine and Immunization Research Forum\, the central forum for research related to Immunization Agenda 2030\, brings together the entire vaccine and immunization research community every two years and is organized by the U.S. National Institute of Allergy and Infectious Diseases\, the Bill & Melinda Gates Foundation\, and the World Health Organization. Between biennial meetings\, a series of webinars is also organized to address emerging issues of interest.
URL:https://carb-x.org/event/global-vaccine-and-immunization-research-forum/
LOCATION:VIRTUAL EVENT
END:VEVENT
END:VCALENDAR